Chicago Partners Investment Group LLC - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
Chicago Partners Investment Group LLC ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$304,416
-73.1%
25,2000.0%0.02%
-72.9%
Q2 2023$1,133,244
-4.3%
25,200
-4.3%
0.06%
-14.5%
Q1 2023$1,184,516
+0.4%
26,346
+1.4%
0.07%
-4.2%
Q4 2022$1,179,868
+2.3%
25,994
-13.9%
0.07%
-12.2%
Q3 2022$1,153,000
+273.1%
30,2000.0%0.08%
+272.7%
Q2 2022$309,000
+17.0%
30,2000.0%0.02%
+10.0%
Q1 2022$264,000
-51.8%
30,2000.0%0.02%
-48.7%
Q4 2021$548,000
-26.8%
30,2000.0%0.04%
-26.4%
Q3 2021$749,000
-43.0%
30,200
-50.0%
0.05%
+8.2%
Q2 2021$1,314,000
+44.1%
60,400
+100.0%
0.05%
-34.7%
Q1 2021$912,000
-2.8%
30,2000.0%0.08%
-15.7%
Q4 2020$938,000
+12.6%
30,2000.0%0.09%
-10.1%
Q3 2020$833,000
-27.6%
30,2000.0%0.10%
-31.2%
Q2 2020$1,150,000
+85.2%
30,2000.0%0.14%
+50.0%
Q1 2020$621,000
+4.4%
30,2000.0%0.10%
+31.5%
Q4 2019$595,000
-6.4%
30,2000.0%0.07%
-18.9%
Q3 2019$636,000
-5.9%
30,2000.0%0.09%
-7.2%
Q2 2019$676,00030,2000.10%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Skorpios Trust 3,271,829$125,180,17850.58%
COMMODORE CAPITAL LP 790,000$30,225,4004.60%
Redmile Group, LLC 2,044,389$78,218,3233.39%
SILVERARC CAPITAL MANAGEMENT, LLC 202,561$7,749,9843.20%
Ghost Tree Capital, LLC 275,000$10,522,0003.11%
Avidity Partners Management LP 2,447,000$93,622,2203.11%
Atlas Venture Life Science Advisors, LLC 594,251$22,736,0433.08%
Logos Global Management LP 400,000$15,304,0002.19%
Yiheng Capital Management, L.P. 1,125,791$43,072,7641.70%
Boxer Capital, LLC 831,495$31,8131.56%
View complete list of AKERO THERAPEUTICS INC shareholders